FAQ/Help |
Calendar |
Search |
Today's Posts |
12-18-2009, 01:12 PM | #1 | |||
|
||||
Senior Member
|
From the Business News
(yes, I understand this report is for companies with the funds to obtain it; I just think the whole idea is symptomatic of what is wrong with our health illness system.) http://www.companiesandmarkets.com/S...ease-63862.asp Cost: $1338.00 Central Nervous System Parkinson Disease (Life Science Analytics) Market: Healthcare and Medical Published Date: 08/01/2009 Report Title: Central Nervous System Parkinson Disease Report Type: Market Report Country: Global Number of Pages: 342 Life Science Analytics', Central Nervous System Parkinson Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of parkinson disease drugs by company and by stage as well as a summary of the latest news and developments in this area.
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
|
|